Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular applications

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5653-5669

  Stout, David A ^a,b   Yoo, Jennie ^b   Santiago Miranda, Adriana Noemi ^c   Webster, Thomas J ^a,d,e  

^a Brown University   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d BROWN UNIVERSITY   (United States)

^e Northeastern University   (United States)

Author keywords

Carbon nanofibers; Cardiomyocytes; Conductive; Nanoroughness; Nanotechnology; Poly(lactic co glycolic acid); Protein adsorption

Indexed keywords

ACTIN; ALPHA SARCOMERIC ACTIN; CARBON NANOFIBER; CONNEXIN 43; FIBRONECTIN; NANOCOMPOSITE; POLYGLACTIN; TROPONIN T; UNCLASSIFIED DRUG; VITRONECTIN;

ADSORPTION KINETICS; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; CELL ADHESION; CELL DENSITY; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; COMPOSITE MATERIAL; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NANOENGINEERING; NANOFABRICATION; PROTEIN EXPRESSION; TENSILE STRENGTH; WETTABILITY;

BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ELASTIC MODULUS; ELECTRIC CONDUCTIVITY; HUMANS; LACTIC ACID; MATERIALS TESTING; MYOCYTES, CARDIAC; NANOSTRUCTURES; POLYGLYCOLIC ACID; SURFACE PROPERTIES; TENSILE STRENGTH;

EID: 84870330023     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34574     Document Type: Article

References (56)

1. Alpert JS, Thygesen K. A call for universal definitions in cardiovascular disease. Circulation. 2006;114(8):757-758.
2. Maton A. Human Biology and Health. Englewood Cliffs, NJ: Prentice Hall; 1993.
3. Lloyd-Jones D, Adams RJ, Brown TM, etal. Executive Summary: Heart Disease and Stroke Statistics-2010 Update. Circulation. 2010;121(7):948-954.
4. Björn D. Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol. 2010;105 Suppl 1:3A-9A.
5. Dzau VJ, Antman EM, Black HR, etal. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes. Circulation. 2006;114(25):2850-2870.
6. Germani A, Di Rocco G, Limana F, Martelli F, Capogrossi MC. Molecular mechanisms of cardiomyocyte regeneration and therapeutic outlook. Trends Mol Med. 2007;13(3):125-133.
7. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23(7):845-856.
8. Cohen S. Rebuilding broken hearts. Sci Am. 2004;291(5):44.
9. Vunjak-Novakovic G, Tandon N, Godier A, etal. Challenges in cardiac tissue engineering. Tissue Eng Part B Rev. 2009;16(2):169-187.
10. Saw SH, Wang K, Yong T, Ramakrishna S. Polymeric nanofibers in tissue engineering. In: Nanotechnologies for the Life Sciences. Weinheim, Germany: Wiley-VCH Verlag GmbH and C, KGaA; 2007.
11. Cappelletti M, Muggleton N, Walsh V. Quantity without numbers and numbers without quantity in the parietal cortex. Neuroimage. 2009;46(2):522-529.
12. Shuangyin W, Noel K, Sanping J, Xin W. Controlled synthesis of dendritic Au@Pt core-shell nanomaterials for use as an effective fuel cell electrocatalyst. Nanotechnology. 2009;20(2):025605.
13. Mu Y, Liang H, Hu J, Jiang L, Wan L. Controllable Pt nanoparticle deposition on carbon nanotubes as an anode catalyst for direct methanol fuel cells. J Phys Chem B. 2005;109(47):22212-22216.
14. Dvir T, Timko BP, Brigham MD, etal. Nanowired three-dimensional cardiac patches. Nat Nanotechnol. 2011;6(11):720-725.
15. Stout DA, Basu B, Webster TJ. Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater. 2011;7(8):3101-3112.
16. Komarneni S. Nanocomposites. J Mater Chem. 1992;2(12): 1219-1230.
17. Chantidis CA. Nanomechanical and nanotribological properties of carbon-based thin films: a review. International Journal of Refractory Metals and Hard Materials. 2010;28(1):51-70.
18. Liu H, Webster TJ. Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials. 2007;28(2):354-369.
19. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6(1):12-21.
20. American Society for Testing and Materials. Standard Test Method for Tensile Properties of Plastics. Vol D638-610. West Conshohocken, PA: American Society for Testing and Materials; 2010.
21. Zheng H-X, Liu S-S, Tian W-M, Yan H-J, Zhang Y, Li Y. A three-dimensional in vitro culture model for primary neonatal rat ventricular myocytes. Current Applied Physics. 2012;12(3):826-833.
22. Tribulova N, Shneyvays V, Mamedova L, etal. Enhanced connexin-43 and α-sarcomeric actin expression in cultured heart myocytes exposed to triiodo-l-thyronine. J Mol Histol. 2004;35(5):463-470.
23. Carrier L, Boheler K, Chassagne C, etal. Expression of the sarcomeric actin isogenes in the rat heart with development and senescence. Circ Res. 1992;70(5):999-1005.
24. Roberts-Thomson KC, Kistler PM, Sanders P, etal. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm. 2009;6(5):587-591.
25. Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol. 2006;48(5):907-913.
26. Engelmayr GC, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater. 2008;7(12):1003-1010.
27. Jalil J, Doering C, Janicki J, Pick R, Shroff S, Weber K. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 1989;64(6):1041-1050.
28. Mirsky I, Parmley WW. Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ Res. 1973;33(2):233-243.
29. Boublik J, Park H, Radisic M, etal. Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng. 2005;11(7-8): 1122-1132.
30. Phillips CA, Petrofsky JS. Myocardial material mechanics: characteristic variation of the circumferential and longitudinal systolic moduli in left ventricular dysfunction. J Biomech. 1984;17(8):561-568.
31. Westerhof N, Stergiopulos N, Noble MIM. Snapshots of Hemodynamics: An Aid for Clinical Research and Graduate Education. New York, NY: Springer; 2010.
32. Yang L, Sheldon BW, Webster TJ. The impact of diamond nanocrystallinity on osteoblast functions. Biomaterials. 2009;30(20):3458-3465.
33. Grinnell F. Fibronectin and wound healing. J Cell Biochem. 1984; 26(2):107-116.
34. Kent SP. Diffusion of plasma proteins into cells-a manifestation of cell injury in human myocardial ischemia. Am J Pathol. 1967;50(4): 623-637.
35. Casscells W, Kimura H, Sanchez JA, Yu ZX, Ferrans VJ. Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol. 1990;137(4):801-810.
36. Willems IE, Arends JW, Daemen MJ. Tenascin and fibronectin expression in healing human myocardial scars. J Pathol. 1996;179(3): 321-325.
37. Landa N, Miller L, Feinberg MS, etal. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117(11):1388-1396.
38. Krupnick AS, Kreisel D, Engels FH, etal. A novel small animal model of left ventricular tissue engineering. J Heart Lung Transplant. 2002;21(2):233-243.
39. Wei H-J, Chen C-H, Lee W-Y, etal. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials. 2008;29(26):3547-3556.
40. Ramaswamy S, Gottlieb D, Engelmayr GC Jr, etal. The role of organ level conditioning on the promotion of engineered heart valve tissue development in vitro using mesenchymal stem cells. Biomaterials. 2010;31(6):1114-1125.
41. Perin EC, Dohmann HF, Borejevic R, etal. Time course of improvement following stem cell injections in humans with heart failure. J Am Coll Cardiol. 2004;43(5):A187.
42. Shintani Y, Fukushima S, Varela-Carver A, etal. Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J Mol Cell Cardiol. 2009;47(2):288-295.
43. Callegari A, Bollini S, Iop L, etal. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials. 2007;28(36):5449-5461.
44. Siepe M, Giraud M-N, Pavlovic M, etal. Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J Thorac Cardiovasc Surg. 2006;132(1):124-131.
45. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res. 2000;51(3):475-483.
46. Miller DC, Thapa A, Haberstroh KM, Webster TJ. Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials. 2004;25(1):53-61.
47. Bal S. Experimental study of mechanical and electrical properties of carbon nanofiber/epoxy composites. Mater Des. 2010;31(5):2406-2413.
48. Pedrotty DM, Koh J, Davis BH, Taylor DA, Wolf P, Niklason LE. Engineering skeletal myoblasts: roles of three-dimensional culture and electrical stimulation. Am J Physiol Heart Circ Physiol. 2005;288(4): H1620-H1626.
49. Mihardja SS, Sievers RE, Lee RJ. The effect of polypyrrole on arteriogenesis in an acute rat infarct model. Biomaterials. 2008;29(31): 4205-4210.
50. Nicolosi A, Weng Z, Detwiler P, Spotnitz H. Simulated left ventricular aneurysm and aneurysm repair in swine. J Thorac Cardiovasc Surg. 1990;100(5):745-755.
51. Sakamoto Y, Mizuno A, Buckberg GD, Baretti R, Child JS, Fonarrow G. Restoring the remodeled enlarged left ventricle: experimental benefits of in vivo porcine cardioreduction in the beating open heart. J Cardiac Surg. 1998;13(6):429-439.
52. Cui J, Li J, Mathison M, etal. A clinically relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materials. Cardiovasc Revasc Med. 2005;6(3):113-120.
53. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23(1):47-55.
54. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater. 2005;4(7):518-524.
55. Mattson M, Haddon R, Rao A. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J Mol Neurosci. 2000;14(3):175-182.
56. Hu H, Ni Y, Montana V, Haddon RC, Parpura V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett. 2004;4(3):507-511.